Potential therapy for MTO1 abnormalities

Posted by & filed under Part 10: DISORDERS OF MITOCHONDRIAL FUNCTION.

Mitochondrial tRNA modification abnormalities are a recently recognized pathologic mechanism leading to defects in oxidative phosphorylation. Genes involved in these modifications include GTPBP3, and MTO1.

Tischner et al (Hum. Mol. Genet. (2015) 24 (8):2247-2266.doi: 10.1093/hmg/ddu743) recently described experiments with a mouse model for MTO1 deficiency, in which implementation of a ketogenic diet was found to subvert the oxidative phosphorylation defect, with effects on mitochondrial and cellular secondary stress responses. 

It is not clear if this intervention has a role in other disorders of mitochondrial tRNA modification, but this is an area worth further exploration, as there is little other specific therapy for affected patients.

Hilary Vernon, MD PhD

 

Leave a Reply

You must be logged in to post a comment.